Intensity of Local Skin Reactions During 5-Fluorouracil Treatment Related to the Number of Actinic Keratosis Lesions: A Post Hoc, Exploratory Analysis
被引:0
|
作者:
Eggert Stockfleth
论文数: 0引用数: 0
h-index: 0
机构:Ruhr-University Bochum,Department of Dermatology
Eggert Stockfleth
Nathalie Bégeault
论文数: 0引用数: 0
h-index: 0
机构:Ruhr-University Bochum,Department of Dermatology
Nathalie Bégeault
Alain Delarue
论文数: 0引用数: 0
h-index: 0
机构:Ruhr-University Bochum,Department of Dermatology
Alain Delarue
机构:
[1] Ruhr-University Bochum,Department of Dermatology
[2] Pierre Fabre Dermatologie,undefined
来源:
Dermatology and Therapy
|
2022年
/
12卷
关键词:
Actinic keratosis;
5-Fluorouracil;
Local skin reactions;
Topical;
D O I:
暂无
中图分类号:
学科分类号:
摘要:
In order to prevent recurrence of actinic keratosis lesions and their progression to invasive squamous cell carcinoma, topical treatment of actinic keratosis often involves treating the field of cancerisation to clear visible and subclinical lesions. The occurrence of local adverse skin reactions during treatment can affect patient adherence to therapy and therefore compromise efficacy. A thorough understanding of the relationships between changes in lesions, actinic keratosis remission and tolerability of topical treatments over time is necessary to manage patient expectations, ensure treatment adherence and optimise clinical outcomes. This exploratory study used pooled data from two pivotal phase III studies to compare local skin reaction severity between 5-fluorouracil 4% cream applied once daily and 5-fluorouracil 5% cream applied twice daily, then to examine the relationship between the severity of local skin reactions during treatment and the number of actinic keratosis lesions at baseline. Local skin reactions appeared to be more severe in patients with more than 10 actinic keratosis lesions at baseline than in those with 5 to 10 lesions. Using a cut-off value of 10 lesions pre-treatment, healthcare practitioners can forewarn patients accordingly of potentially more severe local adverse skin reactions in order to motivate them to complete their treatment, thus ensuring treatment efficacy. If patients are likely to experience intolerable severe skin reactions, practitioners can plan to introduce an appropriate rescue treatment.
机构:
Friedrich Alexander Univ Erlangen Nurnberg, Dept Dermatol, Uniklinikum Erlangen, Erlangen, Germany
Erlangen European Metropolitan Area Nuremberg CC E, Comprehens Canc Ctr, Erlangen, Germany
Bavarian Canc Res Ctr BZKF, Erlangen, GermanyFriedrich Alexander Univ Erlangen Nurnberg, Dept Dermatol, Uniklinikum Erlangen, Erlangen, Germany
Heppt, Markus V.
Trin, Kilian
论文数: 0引用数: 0
h-index: 0
机构:
Pierre Fabre Dermatol, Med Direct Pharmaceut Care & Med Dermatol, Las Cauquillous, F-81500 Lavaur, France
Univ Bordeaux, Med Fac, Bordeaux, FranceFriedrich Alexander Univ Erlangen Nurnberg, Dept Dermatol, Uniklinikum Erlangen, Erlangen, Germany
机构:
Pierre Fabre Labs, Toulouse, FranceFriedrich Alexander Univ Erlangen Nurnberg, Dept Dermatol, Uniklinikum Erlangen, Erlangen, Germany
Groc, Melanie
Delarue, Alain
论文数: 0引用数: 0
h-index: 0
机构:
Pierre Fabre Dermatol, Med Direct Pharmaceut Care & Med Dermatol, Las Cauquillous, F-81500 Lavaur, France
AD Consulting, Toulouse, FranceFriedrich Alexander Univ Erlangen Nurnberg, Dept Dermatol, Uniklinikum Erlangen, Erlangen, Germany
Delarue, Alain
Begeault, Nathalie
论文数: 0引用数: 0
h-index: 0
机构:
Pierre Fabre Dermatol, Med Direct Pharmaceut Care & Med Dermatol, Las Cauquillous, F-81500 Lavaur, FranceFriedrich Alexander Univ Erlangen Nurnberg, Dept Dermatol, Uniklinikum Erlangen, Erlangen, Germany